DK1077694T3 - Arylnitron-terapeutika til behandling af inflammatorisk tarmsygdom - Google Patents

Arylnitron-terapeutika til behandling af inflammatorisk tarmsygdom

Info

Publication number
DK1077694T3
DK1077694T3 DK99922983T DK99922983T DK1077694T3 DK 1077694 T3 DK1077694 T3 DK 1077694T3 DK 99922983 T DK99922983 T DK 99922983T DK 99922983 T DK99922983 T DK 99922983T DK 1077694 T3 DK1077694 T3 DK 1077694T3
Authority
DK
Denmark
Prior art keywords
treatment
inflammatory bowel
bowel disease
arylnitron
therapeutics
Prior art date
Application number
DK99922983T
Other languages
English (en)
Inventor
William D Flitter
William A Garland
Meerveld Beverly Greenwood-Van
Ian Irwin
Original Assignee
Renovis Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Renovis Inc filed Critical Renovis Inc
Application granted granted Critical
Publication of DK1077694T3 publication Critical patent/DK1077694T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Hydrogenated Pyridines (AREA)
DK99922983T 1998-05-19 1999-05-18 Arylnitron-terapeutika til behandling af inflammatorisk tarmsygdom DK1077694T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8596198P 1998-05-19 1998-05-19
EP99922983A EP1077694B1 (en) 1998-05-19 1999-05-18 Aryl nitrone therapeutics for the treatment of inflammatory bowel disease

Publications (1)

Publication Number Publication Date
DK1077694T3 true DK1077694T3 (da) 2004-11-22

Family

ID=22195102

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99922983T DK1077694T3 (da) 1998-05-19 1999-05-18 Arylnitron-terapeutika til behandling af inflammatorisk tarmsygdom

Country Status (11)

Country Link
EP (1) EP1077694B1 (da)
AT (1) ATE271384T1 (da)
AU (1) AU3985599A (da)
CA (1) CA2332462A1 (da)
DE (1) DE69918826T2 (da)
DK (1) DK1077694T3 (da)
ES (1) ES2224660T3 (da)
NZ (1) NZ508176A (da)
PT (1) PT1077694E (da)
SI (1) SI1077694T1 (da)
WO (1) WO1999059576A1 (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6730700B2 (en) 1998-12-02 2004-05-04 Renovis, Inc. 3,4,5,-trisubstituted aryl nitrone compounds and pharmaceutical compositions containing the same
UA66401C2 (en) 1998-12-02 2004-05-17 Sentor Pharmaceuticals Inc 3,4,5-trisubstituted aryl nitrone compounds and pharmaceutical composition containing the same
US20050182060A1 (en) * 2004-02-13 2005-08-18 Kelly Michael G. 2-Substituted and 4-substituted aryl nitrone compounds
ES2395803B1 (es) * 2011-08-01 2013-12-19 Consejo Superior De Investigaciones Científicas (Csic) - 80% Quinolilnitronas

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5036097A (en) * 1989-10-17 1991-07-30 Oklahoma Medical Research Foundation Phenylbutyl nitrone compositions and methods for prevention of gastric ulceration
EP0590072B1 (en) * 1991-06-18 2001-12-05 Oklahoma Medical Research Foundation Use of spin trapping for the treatment of diseases associated with oxidation of lipids and proteins
US5292746A (en) * 1991-09-12 1994-03-08 Merrell Dow Pharmaceuticals Inc. Cyclic nitrones, pharmaceutical compositions thereof and their use in treating shock
US5455272A (en) * 1993-10-22 1995-10-03 Oklahoma Medical Research Foundation Spin trap nitronyl hindered phenols
US5972977A (en) * 1996-04-23 1999-10-26 Centaur Pharmaceuticals, Inc. Ophthalmic pharmaceutical compositions comprising a nitrone compound and methods for treating ocular inflammation using such compositions
MA26553A1 (fr) * 1997-10-17 2004-12-20 Centaur Pharmaceuticals Inc Alpha-aryl-n-alkylnitrones et compositions pharmaceutiques contenant ceux-la

Also Published As

Publication number Publication date
CA2332462A1 (en) 1999-11-25
ES2224660T3 (es) 2005-03-01
PT1077694E (pt) 2004-12-31
ATE271384T1 (de) 2004-08-15
AU3985599A (en) 1999-12-06
EP1077694A1 (en) 2001-02-28
EP1077694B1 (en) 2004-07-21
SI1077694T1 (en) 2004-10-31
NZ508176A (en) 2004-01-30
DE69918826T2 (de) 2004-12-02
DE69918826D1 (de) 2004-08-26
WO1999059576A1 (en) 1999-11-25

Similar Documents

Publication Publication Date Title
DE69612003D1 (de) Substituierte benzolaktamverbindungen als substanz-p-antagonisten
EA200300566A1 (ru) Применение cci-779 в качестве противоопухолевого средства
ATE368031T1 (de) Neue gamma secretase inhibitoren
PT1037886E (pt) Inibidores de angiogenese de triazina
DE60009511D1 (de) Nematizide trifluorbutene
TR200102817T2 (tr) Antiinflamatuar ajanlar olarak faydalı bileşikler
ATE128143T1 (de) 17-beta-substituierte-4-aza-5-alpha-androstan-3 one-derivate und verfahren zu ihrer herstellung.
WO2001035950A3 (en) Benzamide therapeutics and methods for treating inflammatory bowel disease
ATE232873T1 (de) Phosphonsaürederivate als ptp-1b-inhibitoren
DE10082139T1 (de) Zusammensetzung zur Behandlung von Reibungspaaren
ES2243579T3 (es) Derivados de pirazolopirideno.
ATE386742T1 (de) Imidazonaphthyridine
PT971922E (pt) Compostos de tetra-hidropirido
SE9804212D0 (sv) Compounds
TR200002932T2 (tr) Azabisayklik 5HT1 Alıcı liganolları
ATE302002T1 (de) Verwendung von pyrazolderivaten zur behandlung von unfruchtbarkeit
ATE443044T1 (de) Tace inhibitoren
ES2147973T3 (es) Estirenos alquilatados como profarmacos de inhibidores de cox-2.
ATE290857T1 (de) Bretyliumhaltige zusammensetzungen und kits und deren verwendung zur vorbeugung und behandlung cardiovaskulärer erkrankungen
SI1077694T1 (en) Aryl nitrone therapeutics for the treatment of inflammatory bowel disease
WO2001035951A3 (en) Aryl nitrone therapeutics and methods for treating inflammatory bowel disease
NO943765L (no) Aryloksybenzen-herbicidmidler
DK1353660T3 (da) Anvendelse af substituerede 6-dimethylaminomethyl-1-phenylcyclohexanforbindelser til behandling af urininkontinens
DK1078003T3 (da) Plasmin-inhibitorer fra den australske brune slange, pseudonaja textilis textilis
ATE267194T1 (de) Medikamente geeignet zur behandlung von proliferativen erkrankungen